UPDATE: Opko Announces Received Patent from US PTO for Rayaldee, Says On Schedule for NDA Filing During Q1'15

By: via Benzinga
OPKO Health, Inc. (NYSE: OPK), a multinational biopharmaceutical and diagnostics company, today announced that the United States Patent ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.